Skip to content
Clinical Trials – home
Research site

Jorvi Hospital

Finland Turuntie 150, 02740 Espoo, Finland

  • 2 trials recruiting
  • Acute myocardial infarction · Embolism venous · Colorectal cancer
  • Adult patients

About Specializations

Jorvi Hospital in Espoo, Finland specialises in clinical trials of conditions such as Acute myocardial infarction, Embolism venous, Colorectal cancer, Schizophrenia, and other specialisations. This site conducts important research.

Main research areas of the site

Psychiatry and Psychology

At Jorvi Hospital, clinical research in mental disorders focuses on schizophrenia and related cognitive impairment. The main aim is to gather additional safety information and better understand how ongoing treatment strategies may support people living with these conditions.

  • Long-term safety and tolerability research in schizophrenia
  • Support for patients with cognitive symptoms linked to mental illness
  • Evaluation of treatment effects in people who previously participated in a clinical study

This work helps expand knowledge of psychiatric care and supports the development of safer, more effective options for patients with schizophrenia.

Analytical, Diagnostic and Therapeutic Techniques and Equipment

Surgical research at this hospital includes studies on venous thromboembolism in patients undergoing surgery. The focus is on improving prevention strategies and weighing the benefits and risks of thromboprophylaxis for people whose clotting and bleeding risks are not clearly high.

  • Prevention of blood clots after urologic, gynecologic, and abdominal surgery
  • Comparison of standard care alone versus added anticoagulant protection
  • Better understanding of safety and effectiveness in surgical patients

These trials support safer surgical care by refining approaches to blood clot prevention and postoperative risk management.

Neoplasms

In the area of cancer research, the site is studying colorectal cancer, particularly tumors with specific PIK3CA-related alterations. The research aims to see whether an additional treatment approach can help delay recurrence after initial cancer care.

  • Recurrence prevention in stage II-III colon and rectal cancer
  • Research on tumors with somatic changes in the PI3K signaling pathway
  • Evaluation of a treatment strategy to improve long-term cancer control

This line of investigation at Jorvi Hospital is designed to improve outcomes for patients with gastrointestinal cancer by testing whether treatment can reduce the chance of the disease returning.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Turuntie 15002740 EspooFinland
Recruiting now
2 trials
Conditions studied
4

More sites in EspooFinland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:HUS-yhtymae

Colorectal cancer

Not yet recruiting
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Karolinska Institutet
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Iclepertin
  • Sponsor:Boehringer Ingelheim International GmbH
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.